TerminatedNot Applicable

Risk Factors and Biomarkers Associated With Recurrence After Excision of Primary Pterygium

Stopped: Other and future studies on lipiview in pterygium will cover this current trial sufficiently.

Singapore1 participantsStarted 2010-03

Plain-language summary

This study looks at global gene expression in pterygium and found the derangement of matrix genes in particular to be a feature of pterygium. In the investigators opinion, it would be more beneficial to elicit changes in gene expression before the recurrence of pterygium and by developing a panel of biomarkers that are associated with pterygium recurrence; one would be able to predict the post surgical prognosis of patients after resection.Biomarker levels will be compared to discover a biomarker panel for prediction of recurrence.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical diagnosis of primary and recurrence pterygium * Must agree to participate in this study * Must sign informed consent form Exclusion Criteria: * Hepatitis * HIV/AIDS

What they're measuring

biomarkers

Timeframe: 12 months

Trial details

NCT IDNCT01068496

SponsorSingapore National Eye Centre

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2014-12

View on ClinicalTrials.gov More Pterygium trials